Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.
about
Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosisBasic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral OncologyNIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportPhotopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trialInduction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Current and future approaches for control of graft-versus-host disease.Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis.Current issues in chronic graft-versus-host disease.Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure.Chemical and biological mechanisms of pathogen reduction technologiesExtracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.Guidelines on the use of extracorporeal photopheresisExtracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigmaClassic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)Treatment of chronic graft-versus-host disease: Past, present and future.Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.Clinical Results of Extracorporeal PhotopheresisExtracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinionTherapy of chronic graft-versus-host disease.Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.Effect of photopheresis on lymphocyte population in children with newly diagnosed type 1 diabetes.Extracorporeal photopheresis in the management of graft-versus-host disease.Modern aspects of phototherapy for atopic dermatitis.Extracorporeal photopheresis: Review of technical aspectsA Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease.
P2860
Q21132316-5D0C2CB2-75F3-4990-8686-EA5905024BFDQ27026718-0517292A-7471-4960-B035-119E85586647Q28081289-6E4A3C08-ACC2-48A7-A99A-ED47967E6E50Q28344648-39820288-0AC5-4132-94C4-7E2D0B6F8A5DQ30587203-D5147AA6-EC1A-4E57-9709-8149378AE382Q33625948-40D7B05A-6775-47C5-97F3-BBC16F00659DQ33642625-0E590DB3-AC83-494B-B0CE-8E283F0809DBQ33875879-5B6AA4C0-A04C-4A5C-8082-F4C854FA9B99Q33917187-29D427A9-94AE-49EF-A30D-849324FDBA92Q34135339-82351C67-C471-47EA-9962-B032050252F6Q34463636-78265154-E471-4E3F-825F-914E861D47D2Q34777948-801404FA-EF47-48C2-A2F4-0F70AAB639E2Q34870346-49EB3D83-70A5-4AD1-86C9-0C52B782EBE4Q34918643-31481821-4104-429A-BC17-9AC3C5CF4EA0Q35050513-89325080-08B8-4B47-84DB-863B288FD977Q35084404-6227A200-F702-4E59-A770-AECB08D9EFC4Q35174524-76B4B880-5FB7-4D0B-A15C-BF1CBB8BFCD2Q35524687-2B99521F-B1A5-4BDD-ACF3-750EAD61076CQ35737437-1E132AC0-E782-47D7-9789-A65DC28061B6Q36036186-414C62D7-A8B1-482D-8B19-9CED31523868Q36210320-2365531D-A0FD-4ABD-B7DC-2B9E1753F888Q37154179-BEC71A06-4424-4D41-A5EB-647D075BE6EDQ37173479-8549D3CB-A9EB-4F90-9F65-2067C96410A4Q37453628-056770DF-5FFD-4D88-9C41-EAAC3CD11DACQ37494973-4600A7CD-194D-4275-83B4-D699CC13D201Q37719634-34557D36-B15E-418F-AF9D-BED56227A643Q40008863-249D4DED-7A0F-4CFE-942D-4E556A4ABCA8Q41953441-BFCD6ADA-156A-4D68-8412-278D5DBFB7A7Q55405639-D656DADB-4A6C-440E-8C4E-A4593A2DFFC5
P2860
Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Successful use of extracorpore ...... nic graft-versus-host disease.
@ast
Successful use of extracorpore ...... nic graft-versus-host disease.
@en
type
label
Successful use of extracorpore ...... nic graft-versus-host disease.
@ast
Successful use of extracorpore ...... nic graft-versus-host disease.
@en
prefLabel
Successful use of extracorpore ...... nic graft-versus-host disease.
@ast
Successful use of extracorpore ...... nic graft-versus-host disease.
@en
P2093
P1433
P1476
Successful use of extracorpore ...... nic graft-versus-host disease.
@en
P2093
Gmeinhart B
Greinix HT
Guevara-Pineda C
Hönigsmann H
Knobler RM
Krutmann J
Rabitsch W
Volc-Platzer B
P304
P407
P577
1998-11-01T00:00:00Z